Citi downgrades Cano Health to 'neutral' with a price target of $0.80

  • Investing.com
Citi downgrades Cano Health to 'neutral' with a price target of $0.80

An analyst from Citi downgraded Cano Health (NYSE: CANO ) from 'buy' to 'neutral' with a price target of $0.80 from a prior price target of $4.00.

Prior to this rating, Cano Health had 3 buy ratings, 5 hold ratings, and 2 sell ratings.

For consensus analyst estimates and price targets on Cano Health, click here. For more news on Cano Health, click here.

Cano Health's stock price closed at $1.52. They are up 8.57% in the last month and down -70.31% in the last 12 months.

According to Investing Pro, Cano Health's fair value is $1.97, an upside of 29.65%. Cano Health's fair value comes with a medium degree of uncertainty, according to InvestingPro.

Check out Cano Health's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100